|
KMO expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.922600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.145800E-01 |
| Normal-vs-Stage2 |
2.219700E-02 |
| Normal-vs-Stage3 |
5.469200E-01 |
| Normal-vs-Stage4 |
6.822800E-01 |
| Stage1-vs-Stage2 |
1.993620E-04 |
| Stage1-vs-Stage3 |
2.818400E-01 |
| Stage1-vs-Stage4 |
5.223000E-01 |
| Stage2-vs-Stage3 |
1.048460E-02 |
| Stage2-vs-Stage4 |
6.420100E-02 |
| Stage3-vs-Stage4 |
9.078000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.392600E-01 |
| Normal-vs-AfricanAmerican |
4.483000E-01 |
| Normal-vs-Asian |
1.573370E-01 |
| Caucasian-vs-AfricanAmerican |
3.812600E-01 |
| Caucasian-vs-Asian |
1.237730E-02 |
| AfricanAmerican-vs-Asian |
7.837800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.041000E-01 |
| Normal-vs-Female |
3.685200E-01 |
| Male-vs-Female |
7.914300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.221400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.211000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.446800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.913600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.229800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.078600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.712400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.552020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.928630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.839640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.708600E-01 |
| Classical-VS-Follicular |
1.464120E-03 |
| Classical-VS-Other |
1.263630E-02 |
| Classical-VS-Normal |
9.022000E-01 |
| Tall-VS-Follicular |
5.075700E-02 |
| Tall-VS-Other |
6.512400E-02 |
| Tall-VS-Normal |
7.444800E-01 |
| Follicular-VS-Other |
5.707400E-01 |
| Follicular-VS-Normal |
5.109800E-02 |
| Other-VS-Normal |
8.816500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.117400E-01 |
| Normal-vs-N1 |
1.874160E-01 |
| N0-vs-N1 |
5.006800E-01 |
|
|
